Therefore, somatic inactivation of REV3L may result in the accumulation of unrepairable DNA DSBs, which makes tumor cells vulnerable to dacomitinib-mediated inhibition of HR repair21, 27, 28. The gene discussed is REV3L; the disease is neoplasm.